INSM EBITDA | INSMED INC

INSMED INC (INSM) EBITDA

2026-06-30: Basis Reported; EBITDA (m); Operating income -$1.55M; Depreciation and amortization (m).
2026-03-31: Basis Reported; EBITDA (m); Operating income -$153.32M; Depreciation and amortization (m).
2025-09-30: Basis Reported; EBITDA (m); Operating income -$366.00M; Depreciation and amortization (m).
2025-06-30: Basis Reported; EBITDA (m); Operating income -$312.88M; Depreciation and amortization (m).

Complete source-backed ebitda history.

Available history: 2009-12-31 to 2023-12-31
Data captured: 2026-09-04

Historical EBITDA

EBITDA 3 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2026-06-30	Reported	(m)	-$1.55M	(m)	$425.49M	(m)	$6.26M*	-$88.83M*	$67.21M	$210.03M	$247.47M	$1.87M
2026-03-31	Reported	(m)	-$153.32M	(m)	$305.96M	(m)	$3.48M	-$222.74M	$47.42M	$209.49M	$247.26M	$1.47M
2025-09-30	Reported	(m)	-$366.00M	(m)	$142.34M	(m)	$2.42M*	-$219.76M*	$29.36M	$186.41M	$186.38M	$1.32M
2025-06-30	Reported	(m)	-$312.88M	(m)	$107.42M	(m)	$3.48M*	-$205.57M*	$28.07M	$177.19M	$154.76M	$1.24M
2025-03-31	Reported	(m)	-$248.14M	(m)	$92.82M	(m)	$10.07M	-$262.09M	$21.28M	$152.58M	$147.54M	$912.00K
2024-09-30	Reported	(m)	-$213.43M	(m)	$93.42M	(m)	$3.69M*	-$180.92M*	$21.17M	$150.81M	$118.93M	$1.01M
2024-06-30	Reported	(m)	-$288.90M	(m)	$90.34M	(m)	$6.78M*	-$122.95M*	$20.96M	$146.75M	$106.57M	$838.00K
2024-03-31	Reported	(m)	-$145.50M	(m)	$75.50M	(m)	$4.68M	-$184.03M	$17.46M	$121.08M	$93.10M	$589.00K
2023-09-30	Reported	(m)	-$147.67M	(m)	$79.07M	(m)	$2.85M*	-$136.33M*	$16.71M	$109.15M	(m)	$544.00K
2023-06-30	Reported	(m)	-$235.53M	(m)	$77.23M	(m)	$4.88M*	-$122.79M*	$16.59M	$196.97M	(m)	$530.00K
2023-03-31	Reported	(m)	-$148.16M	(m)	$65.21M	(m)	$3.40M	-$146.30M	$13.83M	$127.86M	(m)	$483.00K
2022-09-30	Reported	(m)	-$127.70M	(m)	$67.73M	(m)	$582.00K*	-$89.83M*	$13.47M	$99.87M	(m)	$372.00K
2022-06-30	Reported	(m)	-$88.32M	(m)	$65.22M	(m)	$2.90M*	-$102.30M*	$16.39M	$88.53M	(m)	$501.00K
2022-03-31	Reported	(m)	-$89.83M	(m)	$53.11M	(m)	$1.70M	-$105.16M	$12.19M	$84.36M	(m)	$385.00K
2021-09-30	Reported	(m)	-$103.62M	(m)	$46.76M	(m)	$1.48M*	-$75.44M*	$10.18M	$70.35M	(m)	-$2.58M
2021-06-30	Reported	(m)	-$88.57M	(m)	$45.37M	(m)	$3.48M*	-$75.44M*	$10.84M	$64.66M	(m)	$622.00K
2021-03-31	Reported	(m)	-$83.83M	(m)	$40.21M	(m)	$1.18M	-$128.28M	$9.84M	$61.39M	(m)	$239.00K
2020-09-30	Reported	(m)	-$56.22M	(m)	$43.64M	(m)	$747.00K*	-$58.67M*	$10.62M	$41.41M	(m)	$317.00K
2020-06-30	Reported	(m)	-$54.11M	(m)	$42.49M	(m)	$1.88M*	-$35.95M*	$9.95M	$35.75M	(m)	$428.00K
2020-03-31	Reported	(m)	-$60.36M	(m)	$36.86M	(m)	$2.68M	-$57.94M	$8.44M	$36.18M	(m)	$36.00K
2019-12-31	Reported	(m)	-$47.08M	(m)	$45.71M	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Reported	(m)	-$56.49M	(m)	$38.88M	(m)	$14.59M*	-$52.37M*	$6.44M	$34.34M	(m)	$148.00K
2019-06-30	Reported	(m)	-$62.17M	(m)	$29.97M	(m)	$10.61M*	-$80.03M*	$4.92M	$33.54M	(m)	$90.00K
2019-03-31	Reported	(m)	-$69.51M	(m)	$21.90M	(m)	$4.03M	-$73.85M	$4.15M	$31.20M	(m)	$215.00K
2018-12-31	Reported	(m)	-$87.72M	(m)	$9.84M	(m)	(m)	(m)	$2.42M	(m)	(m)	(m)
2018-09-30	Reported	(m)	-$83.98M	(m)	$0.00	(m)	$1.85M*	-$65.49M*	$0.00	$39.54M	(m)	$46.00K
2018-06-30	Reported	(m)	-$72.88M	(m)	$0.00	(m)	$2.85M*	-$54.91M*	$0.00	$35.72M	(m)	$40.00K
2018-03-31	Reported	(m)	-$62.75M	(m)	$0.00	(m)	$5.37M	-$67.41M	$0.00	$30.10M	(m)	$48.00K
2017-12-31	Reported	(m)	-$65.35M	(m)	$0.00	(m)	(m)	(m)	$0.00	(m)	(m)	(m)
2017-09-30	Reported	(m)	-$44.08M	(m)	$0.00	(m)	$447.00K*	-$38.24M*	$0.00	$26.68M	(m)	$27.00K
2017-06-30	Reported	(m)	-$43.52M	(m)	$0.00	(m)	$437.00K*	-$36.25M*	$0.00	$26.87M	(m)	$37.00K
2017-03-31	Reported	(m)	-$35.97M	(m)	$0.00	(m)	$417.00K	-$36.91M	$0.00	$22.25M	(m)	$30.00K
2016-12-31	Reported	(m)	-$67.05M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Reported	(m)	-$37.15M	(m)	(m)	(m)	$1.30M*	-$30.98M*	(m)	$23.43M	(m)	$25.00K
2016-06-30	Reported	(m)	-$36.13M	(m)	(m)	(m)	$1.54M*	(m)	(m)	$23.87M	(m)	$18.00K
2016-03-31	Reported	(m)	-$33.07M	(m)	(m)	(m)	$588.00K	(m)	(m)	$20.55M	(m)	$28.00K
2015-12-31	Reported	(m)	-$32.59M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Reported	(m)	-$30.25M	(m)	(m)	(m)	$853.00K*	(m)	(m)	$19.22M	(m)	(m)
2015-06-30	Reported	(m)	-$27.95M	(m)	(m)	(m)	$930.00K*	(m)	(m)	$18.25M	(m)	(m)
2015-03-31	Reported	(m)	-$26.71M	(m)	(m)	(m)	$1.26M	(m)	(m)	$17.16M	(m)	(m)
2014-12-31	Reported	-$22.69M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Reported	-$23.05M*	-$23.40M	$355.00K*	(m)	(m)	$2.92M*	(m)	(m)	$15.20M	(m)	$0.00*
2014-06-30	Reported	-$22.64M*	-$22.82M	$175.00K*	(m)	(m)	$564.00K*	(m)	(m)	$14.94M	(m)	$0.00*
2014-03-31	Reported	-$17.91M	(m)	(m)	(m)	(m)	$331.00K	(m)	(m)	$11.35M	(m)	-$4.39M
2013-12-31	Reported	-$15.39M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Reported	-$16.67M*	-$16.84M	$171.00K*	(m)	(m)	$220.00K*	(m)	(m)	$12.10M	(m)	$0.00
2013-06-30	Reported	-$8.11M*	-$8.27M	$156.00K*	(m)	(m)	$330.00K*	(m)	(m)	$12.22M	(m)	$0.00
2013-03-31	Reported	-$14.16M	(m)	(m)	(m)	(m)	$163.00K	(m)	(m)	$10.33M	(m)	-$1.22M
2012-12-31	Reported	-$15.69M	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Reported	-$9.21M*	-$9.35M	$138.00K*	(m)	(m)	$27.00K*	-$9.19M*	(m)	$5.71M	(m)	$0.00
2012-06-30	Reported	-$9.85M*	-$9.98M	$138.00K*	(m)	(m)	$29.00K*	-$7.29M*	(m)	$7.75M	(m)	$2.00K
2012-03-31	Reported	-$7.13M	(m)	(m)	(m)	(m)	$66.00K	-$5.61M	(m)	$4.74M	(m)	$2.00K
2011-12-31	Reported	-$8.76M	(m)	(m)	(m)	-624.38%	(m)	(m)	(m)	(m)	(m)	(m)
2011-09-30	Reported	-$34.88M*	-$34.96M	$79.00K*	(m)	(m)	$487.00K*	-$8.01M*	(m)	$6.93M	$2.47M	$0.00
2011-06-30	Reported	-$10.39M*	-$10.47M	$79.00K*	(m)	(m)	$54.00K*	-$11.02M*	(m)	$8.71M	$2.75M	$0.00
2011-03-31	Reported	-$7.34M	(m)	(m)	(m)	-458.46%	$14.00K	-$5.11M	(m)	$5.76M	(m)	$2.00K
2010-12-31	Reported	-$6.3M	(m)	(m)	(m)	-476.99%	(m)	(m)	(m)	(m)	(m)	(m)
2010-09-30	Reported	-$598.00K*	-$598.00K	$0.00*	(m)	(m)	$0.00*	-$1.04M*	(m)	$769.00K	$1.64M	$77.00K
2010-06-30	Reported	(m)	-$913.00K	(m)	(m)	(m)	(m)	(m)	(m)	$893.00K	$1.88M	$3.00K

EBITDA 12 month

Date	Basis	EBITDA	Operating income	Depreciation and amortization	Revenue	EBITDA margin	Capital spending	Operating cash flow	Cost of products and services	Research and development	Selling, general and administration	Income tax expense / benefit
2025-12-31	Reported	(m)	-$1.25B	(m)	$606.42M	(m)	$32.56M	-$935.01M	$122.94M	$771.09M	$701.17M	$5.03M
2024-12-31	Reported	(m)	-$878.25M	(m)	$363.71M	(m)	$21.92M	-$683.88M	$85.74M	$598.37M	$461.12M	$3.71M
2023-12-31	Reported	-$704.13M	(m)	(m)	(m)	-230.70%	$13.29M	-$536.25M	$65.57M	$571.01M	$344.50M	$2.56M
2022-12-31	Reported	-$452.02M	(m)	(m)	(m)	-184.23%	$9.88M	-$400.44M	$55.13M	$397.52M	$265.78M	$1.38M
2021-12-31	Reported	-$365.99M	(m)	(m)	(m)	-194.20%	$7.29M	-$363.30M	$44.15M	$272.74M	(m)	-$1.76M
2020-12-31	Reported	-$256.13M	(m)	(m)	(m)	-155.79%	$6.24M	-$219.35M	$39.87M	$181.16M	(m)	$1.40M
2020-09-30	Rolling	(m)	-$217.78M*	(m)	$168.71M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-06-30	Rolling	(m)	-$218.04M*	(m)	$163.95M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2020-03-31	Rolling	(m)	-$226.09M*	(m)	$151.43M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-12-31	Reported	-$230.05M	(m)	(m)	(m)	-168.57%	$42.27M	-$250.65M	$24.21M	$131.71M	(m)	$777.00K
2019-12-31	Rolling	(m)	-$235.25M*	(m)	$136.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2019-09-30	Rolling	(m)	-$275.88M*	(m)	$100.59M*	(m)	(m)	(m)	$17.93M*	(m)	(m)	(m)
2019-06-30	Rolling	(m)	-$303.38M*	(m)	$61.71M*	(m)	(m)	(m)	$11.49M*	(m)	(m)	(m)
2019-03-31	Rolling	(m)	-$314.10M*	(m)	$31.74M*	(m)	(m)	(m)	$6.57M*	(m)	(m)	(m)
2018-12-31	Reported	-$303.74M	(m)	(m)	(m)	-3088.34%	$13.09M	-$257.98M	$2.42M	$145.28M	(m)	$201.00K
2018-12-31	Rolling	(m)	-$307.34M*	(m)	$9.84M*	(m)	(m)	(m)	$2.42M*	(m)	(m)	(m)
2018-09-30	Rolling	(m)	-$284.97M*	(m)	$0.00*	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)
2018-06-30	Rolling	(m)	-$245.07M*	(m)	$0.00*	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)
2018-03-31	Rolling	(m)	-$215.70M*	(m)	$0.00*	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)
2017-12-31	Reported	-$186.02M	(m)	(m)	(m)	(m)	$3.00M	-$159.62M	$0.00	$109.75M	(m)	-$272.00K
2017-12-31	Rolling	(m)	-$188.92M*	(m)	$0.00*	(m)	(m)	(m)	$0.00*	(m)	(m)	(m)
2017-09-30	Rolling	(m)	-$190.62M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-06-30	Rolling	(m)	-$183.68M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2017-03-31	Rolling	(m)	-$176.30M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-12-31	Reported	-$171M	(m)	(m)	(m)	(m)	$4.20M	-$146.71M	$0.00	$122.72M	(m)	$98.00K
2016-12-31	Rolling	(m)	-$173.40M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-09-30	Rolling	(m)	-$138.94M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-06-30	Rolling	(m)	-$132.03M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2016-03-31	Rolling	(m)	-$123.85M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-12-31	Reported	-$115.51M	(m)	(m)	(m)	(m)	$3.45M	-$100.70M	(m)	$74.28M	(m)	-$1.97M
2015-12-31	Rolling	(m)	-$117.49M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-09-30	Rolling	(m)	-$107.97M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-06-30	Rolling	(m)	-$101.13M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2015-03-31	Rolling	(m)	-$95.99M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-12-31	Reported	-$86.29M	(m)	(m)	(m)	(m)	$5.35M	(m)	(m)	$56.29M	(m)	-$10.42M
2014-12-31	Rolling	(m)	-$87.36M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-09-30	Rolling	(m)	-$79.89M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-06-30	Rolling	(m)	-$73.33M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2014-03-31	Rolling	(m)	-$58.78M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-12-31	Reported	-$54.34M	(m)	(m)	(m)	-472.48%	$826.00K	(m)	(m)	$44.28M	(m)	-$1.22M
2013-12-31	Rolling	(m)	-$55.02M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-09-30	Rolling	(m)	-$55.26M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-06-30	Rolling	(m)	-$47.77M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2013-03-31	Rolling	(m)	-$49.48M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-12-31	Reported	-$41.88M	(m)	(m)	(m)	(m)	$290.00K	-$31.01M	(m)	$29.78M	(m)	$0.00
2012-12-31	Rolling	(m)	-$42.44M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-09-30	Rolling	(m)	-$35.47M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-06-30	Rolling	(m)	-$61.08M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2012-03-31	Rolling	(m)	-$61.57M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2011-12-31	Reported	-$61.38M	(m)	(m)	(m)	-1389.54%	$979.00K	-$30.20M	(m)	$28.62M	(m)	$0.00
2011-12-31	Rolling	(m)	-$61.72M*	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)	(m)
2010-12-31	Reported	-$8.04M	(m)	(m)	(m)	-116.14%	$0.00	-$7.72M	(m)	$4.70M	(m)	$78.00K
2009-12-31	Reported	-$7.97M	(m)	(m)	(m)	-76.81%	$0.00	-$11.01M	(m)	$9.21M	(m)	$477.00K

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64
Viatris Inc (VTRS)	United States	$20.008B	-0.00
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Jazz Pharmaceuticals plc (JAZZ)		$15.333B	16.07
Summit Therapeutics Inc. (SMMT)	United States	$13.071B	-13.21
BridgeBio Pharma, Inc. (BBIO)	United States	$12.947B	-20.72
CORCEPT THERAPEUTICS INC (CORT)	United States	$12.804B	169.10